SION
Sionna Therapeutics, Inc. Common Stock
NASDAQ: SION · HEALTHCARE · BIOTECHNOLOGY
$45.95
+3.89% today
Updated 2026-05-11
Market cap
$2.07B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.88
Dividend yield
—
52W range
$12 – $48
Volume
0.4M
Sionna Therapeutics, Inc. Common Stock (SION) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating cash flow | $-36.07M | $-43.70M | $-52.79M | $-66.30M |
| Capital expenditures | $1.87M | $1.12M | $27000.00 | $377000.00 |
| Depreciation | $122000.00 | $583000.00 | $668000.00 | — |
| Stock-based comp | $1.69M | $2.26M | $3.71M | $12.07M |
| Free cash flow | $-37.94M | $-44.81M | $-52.81M | $-66.67M |
| Investing cash flow | $-29.26M | $27.35M | $-126.91M | — |
| Financing cash flow | $110.86M | $31000.00 | $178.97M | — |
| Dividends paid | — | — | — | — |
| Share repurchases | — | — | — | — |
| Debt repayment | — | — | — | — |
| Net change in cash | — | — | — | — |